Update shared on 19 Dec 2025
Fair value Increased 53%Analysts have raised their price target on Sasol from approximately $70 to $107 per share, citing a higher assumed future earnings multiple that more than offsets adjusted expectations for revenue growth and profit margins.
What's in the News
- Sasol International Chemicals has launched LIVINEX IO 7, a patent-pending bio-circular surfactant derived from insect oils, positioned as a first of its kind in fabric, home care, industrial and institutional cleaning markets (Key Developments).
- The new surfactant is palm and deforestation free, addressing growing customer and regulatory pressures to reduce reliance on traditional oleochemicals linked to land use change (Key Developments).
- LIVINEX IO 7 utilizes insect oil obtained from black soldier fly larvae, converting organic waste streams into valuable chemical feedstock and improving the sustainability profile of detergent-grade alcohols (Key Developments).
- Because insect oil chemistry closely matches that of vegetable oil, Sasol can rely on mature technologies and existing production processes. This structure may lower scaling risk and capital requirements for the new product line (Key Developments).
Valuation Changes
- Fair value target was raised significantly from $70.00 to $107.00 per share, reflecting a materially higher implied equity valuation.
- The discount rate increased slightly from 23.20% to 23.56%, signaling a modestly higher required return for Sasol's equity risk profile.
- Revenue growth was reduced sharply from 4.24% to 1.10% annually, indicating more conservative assumptions for Sasol's top line expansion.
- The net profit margin was lowered meaningfully from 9.63% to 5.86%, embedding expectations for structurally tighter profitability.
- The future P/E was raised substantially from 3.1x to 8.9x, representing a major re-rating of Sasol's earnings multiple despite more muted operating forecasts.
Have other thoughts on Sasol?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
